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Aims Cardiomyocyte b2-adrenergic receptor (b2AR) cyclic adenosine monophosphate (cAMP) signalling is regulated by the
receptors’ subcellular location within transverse tubules (T-tubules), via interaction with structural and regulatory pro-
teins, which form a signalosome. In chronic heart failure (HF), b2ARs redistribute from T-tubules to the cell surface,
which disrupts functional signalosomes and leads to diffuse cAMP signalling. However, the functional consequences of
structural changes upon b2AR-cAMP signalling during progression from hypertrophy to advanced HF are unknown.
....................................................................................................................................................................................................
Methods
and results
Rat left ventricular myocytes were isolated at 4-, 8-, and 16-week post-myocardial infarction (MI), b2ARs were
stimulated either via whole-cell perfusion or locally through the nanopipette of the scanning ion conductance
microscope. cAMP release was measured via a Fo¨rster Resonance Energy Transfer-based sensor Epac2-camps.
Confocal imaging of di-8-ANNEPS-stained cells and immunoblotting were used to determine structural alterations.
At 4-week post-MI, T-tubule regularity, density and junctophilin-2 (JPH2) expression were significantly decreased.
The amplitude of local b2AR-mediated cAMP in T-tubules was reduced and cAMP diffused throughout the cytosol
instead of being locally confined. This was accompanied by partial caveolin-3 (Cav-3) dissociation from the mem-
brane. At 8-week post-MI, the b2AR-mediated cAMP response was observed at the T-tubules and the sarcolemma
(crest). Finally, at 16-week post-MI, the whole cell b2AR-mediated cAMP signal was depressed due to adenylate
cyclase dysfunction, while overall Cav-3 levels were significantly increased and a substantial portion of Cav-3 disso-
ciated into the cytosol. Overexpression of JPH2 in failing cells in vitro or AAV9.SERCA2a gene therapy in vivo did
not improve b2AR-mediated signal compartmentation or reduce cAMP diffusion.
....................................................................................................................................................................................................
Conclusion Although changes in T-tubule structure and b2AR-mediated cAMP signalling are significant even at 4-week post-MI,
progression to the HF phenotype is not linear. At 8-week post-MI the loss of b2AR-mediated cAMP is temporarily
reversed. Complete disorganization of b2AR-mediated cAMP signalling due to changes in functional receptor local-
ization and cellular structure occurs at 16-week post-MI.
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1. Introduction
Heart failure (HF) is a complex clinical syndrome arising from myocardial
injury or dysfunction. Together with other cardiovascular complications,
HF accounts up to 40% of all deaths worldwide.1 HF does not occur in-
stantaneously but develops over time due to mechanical and hormonal
stresses and adverse cardiac remodelling, as shown in multiple human
studies and recapitulated in animal models.2 The stages of disease pro-
gression may manifest themselves, at first, as compensatory hypertrophy
then as decompensated hypertrophy and finally as HF. When HF de-
velops, ventricular myocytes undergo a plethora of functional and struc-
tural changes.3,4 During the initial phase of HF progression, the
sympathetic nervous system compensates for the diminished cardiac
output through an increase in catecholaminergic stimuli3 and cardiomyo-
cytes experience hypertrophic growth.5 This results in transiently advan-
tageous changes in the b-adrenergic receptor (b-AR)- and cyclic
adenosine monophosphate (cAMP)-dependent inotropic response of
cardiomyocytes4 but transforms into a maladaptive decrease of myocar-
dial responsiveness at more advanced stages of HF.6,7
The b1- and b2ARs constitute the predominant receptor pathways for
the sympathetic control of myocardial function. Diverse mechanisms
have evolved to translate signalling via these two molecules into differen-
tial effects on physiology. b1ARs but not b2ARs stimulate the cAMP-
dependent protein kinase (PKA)-mediated phosphorylation of phospho-
lamban and cardiac contractile proteins,8 induce hypertrophy upon
moderate overexpression,9,10 and promote cardiomyocyte apop-
tosis.8,11 In mouse ventricular myocytes, we have shown that, upon local
receptor stimulation, b1-AR-mediated cAMP signalling propagated
throughout the entire cell, whereas b2AR-cAMP responses were locally
confined.12 In HF, secondary to changes in cardiomyocyte structure, the
b2AR-cAMP response was no longer exclusively detectable in the trans-
verse tubules (T-tubules) but also appeared in the crests, dome shaped,
interspersing plasma membrane areas between T-tubule openings.13
This results in uncoupling of b2ARs from the localized pools of PKA that
are responsible for the compartmentation of the b2AR-cAMP signal-
ling.14–16 Thus, in failing cells, activation of b2ARs leads to cell-wide
cAMP signal propagation patterns similar to the patterns observed for
b1ARs, which may account for the loss of its normally cardioprotective
properties and its contribution to the HF phenotype.17 The transverse
axial tubule (TAT) system, which includes the T-tubules as well as longi-
tudinally directed elements, plays an important role in signal transduction
and cell homeostasis.18 It develops gradually in postnatal cardiomyocytes
in a process, which is associated to the structural regulation and modifi-
cation by multiple structural proteins, including among many others
junctophilin-2 (JPH2) and the T-tubule as well as JPH2 associated
Caveolin 3 (Cav-3).19 Although JPH2 appears to anchor the SR close to
the T-tubule membranes,20 Cav-3 has been associated to caveolae,
nanometer sized, bubble-like invaginations of the cell membrane, which
may be the precursors of T-tubules.21 Cav-3 has also been shown to
play a prominent role in cell signal regulation22 including the b2AR sig-
nalling pathway.23 Alterations in T-tubule associated structural proteins
and disruption of the TAT system have been shown to be concurrent
with HF in animal models and human cardiomyocytes.24–27 As HF is a
progressive disease, the time dependent changes in cardiomyocytes re-
garding b2AR-cAMP signalling and cell structure during the progression
of left ventricular (LV) hypertrophy to advanced HF need further
investigation.
Here, we hypothesized that disruption of T-tubular microdomains
during the progression of LV hypertrophy to advanced HF, may have an
impact on b2ARs-cAMP response location thus promoting diffuse patho-
logical signalling. We used scanning ion conductance microscopy (SICM),
Fo¨rster Resonance Energy Transfer (FRET) and confocal imaging to visu-
alize cell surface topography and T-tubule network and to investigate
the compartmentalization of b2AR-cAMP signalling in rat LV myocytes
isolated at 4-, 8-, and 16-week post-myocardial infarction (MI). In cardio-
myocytes transduced with the Epac2-camps cAMP-FRET sensor, b2ARs
were stimulated either via whole-cell perfusion or locally (in or outside
of the T-tubule) via a SICM nanopipette. In addition, cAMP diffusion was
investigated in cardiomyocytes isolated from 16-week post-MI rats,
which underwent sarcoplasmic reticulum Ca2þ pump 2a (SERCA2a)
gene therapy. In tandem we investigated the total protein levels of the
T-tubule associated proteins JPH2 and Cav-3 as well as Cav-3 levels in
the membrane and cytosol fractions of cells.
2. Methods
Detailed methods and further information are provided in the
Supplementary material online.
2.1 Animals
All procedures were carried out according to the standards for the care
and use of animal subjects determined by the UK Home Office
(ASPA1986 Amendments Regulations 2012) incorporating the EU dir-
ective 2010/63/EU. The Animal Welfare and Ethical Review Body
Committee of Imperial College London approved all protocols.
2.2 MI model
Myocardial infarction (MI) was induced by ligation of the left anterior des-
cending coronary artery of male, adult Sprague-Dawley rats as described
previously in24 and in the supplementary detailed methods section.
Animals were only used for operation once they had reached a body
weight of 250 g. Echocardiography measurements in M-mode were per-
formed (Figure 1A) on some of the animals. Before animals were sacrificed
by cervical dislocation they were exposed to 5% isoflurane until they lost
their righting reflex. Body weight, heart weight, tibia length (TL) and ante-
roseptal as well as posterior wall (PW) thickness were determined from
the sacrificed animals. Cardiomyocytes were isolated from the LV of age
matched control hearts and hearts 4-, 8-, and 16-week post-MI.
2.3 Scanning of cardiomyocyte surface,
TAT structure evaluation and cell size
determination
Cardiomyocyte topography scans were obtained using SICM with nano-
pipettes of 100 MX resistance, as described previously.28 The
Z-groove index was calculated to quantify changes in surface structures
of control and MI cells, as described previously in.29
Cardiomyocytes were stained with the lipophilic dye Di-8-ANEPPS
and imaged using an inverted confocal microscope (Zeiss LSM-780) to
measure T-tubule regularity, density and the amount of longitudinal
elements as well as single cardiomyocyte lengths, heights, widths and
overall cell volume (see supplementary material online, Figure S2).
Three-dimensional representations of the T-tubule network were gen-
erated from confocal images (see Supplementary material online,
Movies). For illustration of how the aforementioned parameters were
determined see supplementary material online, Figure S8 and S9.
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..2.4 JPH2 and caveolin-3 protein level
quantification and cell fractionation
Relative amounts of JPH2 and caveolin-3 (Cav-3) were measured by
densitometry of protein bands following Western blotting with spe-
cific antibodies (JPH-2 goat polyclonal, Santa Cruz, sc-51313; Cav-3
monoclonal mouse, Santa Cruz, sc-5310; and normalization to
glycerinaldehyd-3-phosphat-dehydrogenase (GAPDH) (mouse mono-
clonal, BioTrend Chemikalien GmbH, no. 5G4-6C5) and calsequestrin
(CSQ) (rabbit polyclonal, Thermo Scientific, PA1-913) levels. For this,
cells from three animals for each condition were used and all blots were
performed in three replicates. Additionally, Cav-3 levels in membrane
and cytosolic fractions of control cells and cardiomyocytes at 4- and 16-
week post-MI were determined. In order to investigate Cav-3 dissoci-
ation from the membrane into the cytosol, we took advantage of the
protein not being dissolvable in Triton, but sodium dodecyl sulphate and
performed cell fractionation as is described in detail in the supplemen-
tary material online.
2.5 Measurement of ß2AR-dependent
cAMP signalling after whole-cell
stimulation
The amount of cAMP produced following activation of b2AR was deter-
mined with a FRET-based method. Cardiomyocytes were transduced
with adenovirus encoding Epac2-camps construct for 48 hours as
described previously in.13 Then the cells were pre-incubated with b1-AR
blocker CGP20712A (CGP, 100 nmol/L) for 5 min before perfusing with
nonspecific ß-AR agonist isoproterenol (ISO, 100 nmol/L) to measure
b2AR-dependent cAMP production. At the end of the experiment, max-
imal cAMP production was measured by activation of adenylate cyclase
(AC) using the forskolin analogue NKH477 (NKH, 5mmol/L).
2.6 Measurement of ß2-AR-dependent
cAMP signalling after local stimulation
Control cells and cells post-MI were transduced as above. Topographical
images were obtained by SICM. CGP20712A (100 nmol/L) was added to
the cell bath at least 5 min before b2ARs were stimulated locally via the
SICM nanopipette by pressure application of the agonist into either a
T-tubule opening or onto a crest area with pipette solution containing
ISO (10 mmol/L) and CGP20712A (10 mmol/L) as described previously13.
Additionally, cells 4-week post MI were pre-treated with pertussis toxin
(PTX, 1.5 mg/ml) for 3 h before local stimulation. b2AR-dependent cAMP
diffusion distance was determined for control cells and cells isolated from
animals post-MI and from animals which underwent SERCA2a gene ther-
apy as described previously in.30
2.7 Statistical analysis
A two-tailed t-test was used for the comparison between independent
groups of normally distributed data as determined by Kolmogorov-
Smirnov testing. One-way analysis of variance (ANOVA) followed by
Bonferroni correction post hoc testing was used for simple two-group
comparison. Datasets of a hierarchical nature, i.e. data for which single
cardiomyocytes were assigned to their respective animals and sub-
grouped accordingly, were compared with a mixed ANOVA followed
by Wald v2-test. All data are presented as scatter/dot plots with means
and standard errors.
Figure 1 Rat heart size increases while heart function declines progressively post-MI (A) Echocardiography data; Top panel: Echocardiography image indi-
cating the plane (white punctuated line) in the LV from which echocardiography data represented in the bottom panel was collected, over time. LA marks
the location of the left atrium and AO marks the aorta. Bottom panel: echocardiography data showing the ASW and the PW function of the LV.
(B) Echocardiography data at different time points post-MI; (C) Ejection fraction at different time points post-MI, sample numbers in control followed by
chronological order of MI samples: n = 10, n = 15, n = 8, n = 15; (D) Heart weight corrected to TL at different time points post-MI, each time point n = 10;
Control rats were from an even spread of time points 4 at 4-week, 4 at 8-week, and 3 at 16-week post-MI; N, number of animals, **P < 0.001, ***P < 0.0001
as determined with one-way ANOVA followed by Bonferroni post hoc correction.
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3. Results
3.1 HF phenotype progression
After coronary ligation, the anteroseptal wall (ASW) of the LV becomes
scarred and akinetic (Figure 1A). In addition, there was progressive dys-
function and hypokinesis of the PW, which was clearly seen at 16-week
post-MI (Figure 1B). The LV ejection fraction declined progressively over
time, with the greatest reduction occurring between 8- and 16-week
post-MI (Figure 1C). Eccentric, single cell hypertrophy subsequently de-
veloped as early as 4-week post-MI to compensate for reduced muscle
function (see supplementary material online, Figure S2B) and an overall
increase in cardiomyocyte volume was detectable at 8- and 16-week
post-MI (see supplementary material online, Figure S2C,D). By 4-week
post-MI, there was a marked increase of heart weight to TL ratio (by
16% compared with controls, P < 0.05) with a gradual further increase
over time (Figure 1D). Hence, consistent with progressive adverse
remodelling observed in humans,27 MI rats also experience progressive
cardiac remodelling.
3.2 TAT network remodelling
In healthy cardiomyocytes, the TAT network spans the entire cytoplasm
and consists of periodically spaced T-tubules and irregular longitudinal
elements that connect the T-tubules (Figure 2A, middle panels).31 On the
cardiomyocyte surface, T-tubule openings could be clearly visualized by
SICM, which allowed a detailed characterization of topographical struc-
tures, with clear distinction of T-tubule openings and crests between Z-
grooves (Figure 2A, left panels). Profile measurements of topographical
images showed that in adult, healthy ventricular myocytes, spacing be-
tween Z-grooves is 2lm, corresponding to the sarcomere length.29
HF resulted in significant remodelling in both TAT and topography struc-
tures (Figure 2A). Selected area of confocal images of cells stained with
membrane dye Di-8-ANEPPS were analysed for the regularity of T-tu-
bule elements by Fast Fourier transformation. Consistent with other
studies25 our calculations of T-tubule regularity indicate that they were
interspaced highly regularly at 2 mm intervals in healthy cardiomyo-
cytes. In addition, the density of the network was measured on these
images. T-tubule regularity dropped drastically by 47% (P = 0.004)
(Figure 2D) together with a smaller, but significant reduction in TAT
density by11% (P = 0.016) as early as 4-week post-MI, with no further
changes at later time points (Figure 2C). Along with TAT remodelling,
cardiomyocytes from failing rats displayed alterations in their surface
structure,29 which were reflected by a reduced Z-groove index. At 4-
week post-MI, a small decrease in the Z-groove index by 9% (P =
0.0002) was detected (Figure 2B). In contrast to the TAT remodelling,
the reduction of Z-grooves progressed with time, with a further 9% de-
crease at 8- and 16-week post-MI (Figure 2B). Interestingly, in contrast to
the reduction in T-tubule density and regularity, the number of longitu-
dinal elements of the TAT network increased by 41%(P = 0.040) at
4 weeks (Figure 3A,B) and remained elevated until 8 weeks before declin-
ing in line with the overall T-tubule organization at 16-week post-MI.
The membrane bridging protein JPH2 has been implicated in deter-
mining T-tubule orientation and formation.20 We therefore examined
whether the abundance of JPH2 protein changes along with TAT remod-
elling. Western blot results demonstrated that JPH2 expression was al-
ready dramatically reduced as early as 4-week post-MI in two out of
three samples, although there was variability in animals at that stage and
hence the difference was not statistically significant. The differences had
become significant by 8-week post-MI (P < 0.05) and remained low
throughout at the end stage of HF (Figure 3C). Cav-3, another structural
protein associated with JPH2 and T-tubular structure, started partially
dissociating into the cytosol (44% of the overall protein in control,
when adding up membrane and cytosol amounts) at 4-week post-MI (P
< 0.05) (Figure 3E,F,I). Then, at 16-week post-MI, it was significantly
increased about 2.6-fold in comparison to control (P < 0.05) (Figure 3D).
This increase was accompanied by a significant (P < 0.05) and even stron-
ger dissociation of Cav-3 (61% of the overall protein in control, when
adding up membrane and cytosol amounts) from the membranes into
the cytosol of failing cardiomyocytes (Figure 3E,F,H,I). Whole cell Cav-3
and fractionized Cav-3 level measurements were conducted in different
samples from different animals, hence normalized values differ between
blots. Fractionized Cav-3 levels were normalized against GAPDH as this
house keeping gene is simultaneously a cytosolic marker, while overall
Cav-3 levels were normalized against CSQ.
3.3 b2AR-dependent cAMP response after
whole-cell activation
Representative FRET ratio traces recorded in control and cells at 4-, 8-,
and 16-week post-MI during b2AR stimulation are shown in Figure 4A.
We found that at 4-week post-MI, the whole-cell b2ARs-cAMP response
dropped slightly, but significantly by 30% (P = 0.024); however at
8 weeks, we saw the level of response recover to the level observed in
control cells (Figure 4B). At the same time, maximum AC activity did not
change significantly at the first two time points (Figure 4C). At 16-week
post-MI however we observed a concurrent, significant decrease in both
b2AR-dependent cAMP levels by 48%, (P = 0.011) and the overall
cAMP level produced after AC stimulation by63% (P = 0.014), as com-
pared with control cells (Figure 4B,C).
3.4 b2AR localization and cAMP signal
compartmentation
To study compartmentation of the cAMP response in T-tubules, we
stimulated b2ARs locally via the SICM nanopipette. Typical traces of
FRET ratios recorded following local b2AR stimulation on the T-tubules
or on the crests are presented in Figure 5A. As we reported previously
in,13 we observed that in control cardiomyocytes, the b2AR-dependent
cAMP response is five-fold greater in the T-tubule openings than at the
crests (Figure 5A,B,C), whereas in cardiomyocytes isolated from rat hearts
at end stage HF (16-week post-MI), the b2AR-cAMP response was found
to be equally present in T-tubules and in the crests (Figure 5A,B,C). Here
we aimed to study when this b2AR-cAMP response appearance at the
crests occurs first. We found that b2AR-dependent cAMP response fol-
lowing stimulation in T-tubules was strongly reduced as early as 4-week
post-MI (72%, P = 0.004; Figure 5B), whereas no change was detected
following stimulation at crest areas compared with control cells.
Moreover, while the b2AR-dependent cAMP response at the T-tubules
remained low at 8-week post-MI, response to crest stimulation
increased significantly (300%, P = 0.040; Figure 5C). There were no fur-
ther changes in the appearance of b2AR-dependent cAMP response at
16-week post-MI (Figure 5B,C). Thus, the drop in b2AR responsiveness
at the T-tubules precedes the appearance of b2AR-cAMP signals at the
crests.
3.5 Diffusion of the b2AR-dependent cAMP
signal
We have previously shown that cells at 16-week post-MI exhibit a
b2AR-dependent cAMP signal that diffuses throughout the entire cytosol
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Figure 2 Cardiomyocyte surface structures, T-tubule density and regularity decrease and remain decreased from the earliest time point post-MI.
(A) Structural features of cardiomyocytes at various time points; Left panels: representative 10  10mm cell topography scans of cardiomyocytes isolated
from control rat hearts and at different time points post-MI (exemplary Z-grooves and T-tubule openings are highlighted with black arrows). Middle panels:
representative confocal images taken from control and failing cardiomyocytes at different time points post MI. Scale bars = 10 mm. Top insets in confocal
images: zoom of 40  5 mm area of the confocal image; Bottom insets: binarized image represented in the corresponding top inset, used to determine
T-tubule regularity; Right panels: power peaks of T-tubule regularity calculated from confocal images via 1D Fourier Transformation; a single, high peak indi-
cates regular T-tubule distribution at the corresponding distance. (B) Z-groove index, an indicator of surface structural integrity. Sample numbers in control
followed by chronological order of MI samples: N/n = 9/44, N/n = 7/32, N/n = 11/60, N/n = 9/56; (C) Density of T-tubules calculated from binarized images
(TAT density). Sample numbers in control followed by chronological order of MI samples: N/n = 5/25, N/n = 5/25, N/n = 5/25, N/n = 4/20 (D) Power of the
major T-tubule regularity peak calculated from binarized images via 1D Fourier Transformation (regularity power). Sample numbers in control followed
by chronological order of MI samples: N/n = 5/25, N/n = 5/25, N/n = 5/25, N/n = 4/20; N, number of animals, n, number of cells, *P < 0.05, **P < 0.001,
***P < 0.0001 as calculated with mixed ANOVA followed by Wald v2-test.
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..after local stimulation at detubulated areas.13 Here we explored the de-
velopment of this loss of spatial confinement of b2AR-dependent cAMP
signalling after local stimulation in the T-tubule. We considered a re-
sponse as local if the signal had dropped by >50% at 30 mm distance
from the original site of stimulation. We found that following local b2AR
stimulation, cAMP diffused throughout the cytosol as early as 4-week
post-MI (Figure 6A,B), even though b2AR—cAMP signals had not relo-
cated yet to the crest at that time point (Figure 5). The relative cAMP lev-
els at increasing distance to the original site of stimulation inside
T-tubules of cardiomyocytes post infarction were significantly different
from control cells, except for control and cells 4-week post-MI at the
furthest distance to the original site of application (Figure 6A,B). This
indicates that cardiomyocytes at 4-week post MI to some degree still
have some limited cAMP confinement in the cytosol in comparison to
the later stages post-MI.
3.6 SERCA2a therapy restores T-tubular
localization of b2ARs but does not confine
b2AR-cAMP response
Loss of cAMP confinement during the progression of HF seems to cor-
relate better with loss of TAT system regularity and JPH2 expression
than with b2AR-cAMP response appearance at the crests. Previously, we
have shown amelioration of surface structure organization and TAT
Figure 3 Transiently increased occurrence of longitudinal elements in the TAT system is accompanied by a persistent decrease in JPH2 post-MI and dis-
sociation of Cav-3 into the cytosol. The occurrence of longitudinal elements of the TAT system transiently rises while JPH2 levels decrease and remain
decreased from the earliest time point post-MI and Cav-3 levels increase and dissociate from the membrane 16-week post-MI. (A) Top panels: representa-
tive 40 10 mm frames of the confocal images of cardiomyocytes at different time points (Scale bar equals 2lm); Bottom panels: axial elements extracted
mathematically from frames above as explained in ‘Methods’ section; (B) Number of longitudinal tubules; *P < 0.05 as calculated with mixed ANOVA fol-
lowed by Wald v2-test. Sample number N/n = 4/20 each; (C) Representative immunoblots for JPH2 and (D) of Cav-3 as well as the house keeping gene prod-
ucts GAPDH and CSQ, each sample was analysed in triplicates from 3 different animals (control = age matched animals); (E) Representative immunoblots
showing dissociation of Cav-3 protein from membrane to cytosol at 4- and 16-week post-MI. SERCA2a was used as membrane fraction marker and
GAPDH as cytosolic fraction marker. Ponceau staining was performed as overall loading control. (F) and (G) Density of respective JPH2 bands in (C) normal-
ized to corresponding GAPDH bands, n = 3 each, and of Cav-3 bands in (D) normalized to CSQ bands. (H) Density of Cav-3 in cytosolic fractions of cardio-
myocytes 4- and 16-week post-MI normalized to GAPDH in (E). Sample number N = 3 each, N, number of animals; n, number of cells. *P < 0.05 as
determined with one-way ANOVA followed by Bonferroni post hoc correction.
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network regularity in failing rat ventricular myocytes after gene therapy
with SERCA2a expressing adeno-associated virus.30 In our previous pub-
lication,30 we demonstrated that the expression of many structural pro-
teins, including BIN-1 and Tcap, was recovered together with SERCA2a
levels and that the contractile function in SERCA2a-treated animals was
improved in comparison to untreated animals. Here, we re-examined
these cells with regard to their cAMP compartmentation and found
that the b2AR-dependent cAMP signal is still diffuse as in HF cells
(Figure 7A,B), despite the reappearance of b2ARs-cAMP response back
to the T-tubules, as shown previously in.30
3.7 b2AR-dependent cAMP signal
compartmentation in failing
cardiomyocytes is not restored after
overexpression of JPH2
To find out if introducing exogenous JHP2 normalizes cell structure and
restricts b2AR-dependent cAMP response, we transduced failing cells at
16-week post-MI with a virus construct expressing JPH2. Transfection
increased JPH2 expression and greatly restored its regular distribution
throughout the cardiomyocytes (see supplementary material online,
Figure S3B); however, this improved neither cell surface topography (see
supplementary material online, Figure S3C) nor b2AR-dependent cAMP
signalling (see supplementary material online, Figure S4). In cells express-
ing JPH2, the whole-cell FRET response to b2AR stimulation remained
low (see supplementary material online, Figure S4A,B,C) and the AC-
dependent whole-cell cAMP response remained low as well (see supple-
mentary material online, Figure 4A,B,D). In addition, reappearance of the
b2AR-dependent cAMP response back inside the T-tubules did not
occur, as seen from the FRET signal changes after local b2AR stimulation
(see supplementary material online, Figure 5). The signal remained dif-
fuse as opposed to the confined signal seen in non-failing myocytes
(Figure 7B). This data signify that JPH2 alone is not sufficient to confer
local restriction of b2AR signalling in failing cardiomyocytes.
3.8 Changes in Gi coupling release the
b2AR-dependent cAMP response from
T-tubules confinement
b2ARs are known to couple with both Gi and Gs downstream effector
proteins.8 Whereas Gs stimulates AC and leads to cAMP production, ac-
tivation of Gi is known to inhibit cAMP production.
7 The latter is
involved in restricting cAMP signal to T-tubules in non-failing cells, along
with other mechanisms, including phosphodiesterase-dependent cAMP
degradation.13 To determine if the loss of cAMP confinement in failing
cardiomyocytes is due to altered b2AR coupling to Gi, we reanalysed the
results obtained previously in.12 from non-failing ventricular myocytes
treated with PTX. Analysis of cAMP diffusion in these cells showed that
Gi inhibition indeed led to cAMP production becoming more diffuse, in a
manner similar to HF cells (Figure 7B). To investigate the coupling of
Figure 4 The intracellular cAMP response to whole-cell b2AR stimulation undergoes a temporary decline followed by an increase before its depression
at the end stage of HF. (A) Representative traces of the whole-cell FRET following b2AR-specific stimulation with ISO in the presence of selective b1AR an-
tagonist CGP20712A; YFP/CFP ratio is inversely related to the cAMP level; AC agonist NKH477 was later added to elicit maximal cAMP production;
(B) Whole-cell FRET response to the selective b2AR stimulation with ISO at different time points after MI. Sample numbers in control followed by chronolo-
gical order of MI samples: N/n = 9/61, N/n = 5/26, N/n = 7/32, N/n = 9/41; (C) Whole-cell FRET response to NKH477 showing maximal cAMP production.
N, number of animals; n, number of cells. Sample numbers in control followed by chronological order of MI samples: N/n = 7/38, N/n = 4/14, N/n = 7/32, N/n
= 6/26. *P < 0.05, **P < 0.001 as calculated with mixed ANOVA followed by Wald v2-test.
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.b2AR-Gi at the onset of HF, we also stimulated cardiomyocytes at 4-
week post-MI locally inside T-tubules with and without pre-treatment
with PTX (see supplementary material online, Figure 7). Higher or lower
Gi signalling would be reflected in altered b2AR-cAMP levels. However,
we saw no potentiation of the response of b2AR-cAMP by PTX in the T-
tubules of cells 4-week post-MI. This indicates that in myocytes 4-week
post-MI potential b2AR-Gi coupling changes are not the reason for the
observed diffuse signalling.
4. Discussion
This study combines evidence of the structural changes in ventricular
myocytes with the sequelae of functional remodelling of local b2AR-
cAMP signalling during progression of LV hypertrophy to chronic HF A
summary of these alterations during HF progression can be found as a
schematic in Figure 8. Rat hearts that underwent experimental MI experi-
enced a progressive remodelling of the remaining viable cardiomyocytes
contributing to the progressive decrease in ventricular function.
Cardiomyocytes at 4-week post-MI have evidence of early structural and
functional changes, confirming that hypertrophic cellular remodelling
starts early after MI in the remaining myocardium (see supplementary
material online, Figure 2). By 8-week post-MI the cardiomyocyte
remodelling has progressed more towards the chronic HF phenotype
with remodelling of functional b2AR-cAMP signalling in addition to struc-
tural changes. At 16-week post-MI cardiomyocytes are closer to the
end-stage of HF with a severe alteration in all investigated structural fea-
tures (Figure 2 and 3) and the important functional sequalae with reduced
b2AR-cAMP signalling (Figure 4). This classification is corroborated by
other groups using the same experimental, rat model where signs of
advanced HF were observed after 8-week post-MI e.g. reduction of
SERCA2a gene expression,32,33 sympathetic nerve stimulation3 and
whole heart morphological and functional changes.34
4.1 Structural changes during HF
progression
After cardiac injury, the TAT network undergoes progressive and com-
plex structural remodelling. Initially, this involves the increase of longitu-
dinal elements. Disruption of the highly ordered cardiomyocyte
structure, in particular disorganization of the TAT network in the LV, has
been observed in a variety of coronary artery occlusion models.2 After
transverse aortic banding in rat, T-tubular loss of around 10% already ap-
pears in compensated hypertrophy.25 This T-tubular loss becomes much
more severe (up to 86%) at the early onset of HF and at advanced HF.25
However, a recent, more detailed study of the T-tubule system after
Figure 5 The b2AR-dependent cAMP response to local stimulation, dissipates from T-tubules early post-MI to crests at a later time point post-MI.
(A) Representative curves of FRET response after local b2AR stimulation either in T-tubule openings (dotted line) or on crest areas (black line). Local
b2ARs-dependent cAMP FRET response after agonist application (B) into T-tubules, sample numbers in control followed by chronological order of MI sam-
ples: N/n = 5/10, N/n = 6/15, N/n = 4/9, N/n = 5/17, or (C) onto crest, sample numbers in control followed by chronological order of MI samples: N/n = 5/11,
N/n = 5/14, N/n = 4/10, N/n = 6/19. N, number of animals; n, number of cells. *P < 0.05, **P < 0.001, **P < 0.0001 as calculated with mixed ANOVA followed
by Wald v2-test.
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Figure 6 The b2AR-dependent cAMP response, which is confined in
control cells diffuses throughout the whole cytosol at different time
points post-MI. (A) images of cardiomyocytes indicate areas of interest
(coloured ovals) situated at various distances from the point of stimula-
tion (white arrows) where FRET was measured after local selective
stimulation of b2ARs in T-Tubules; Scale bars in, 20 mM (B) colour-
coded curves of FRET response corresponding to the four areas of
interest as indicated on the right panels.(C) Differences of the relative
b2AR-cAMP levels at progressive distances from the point of original
agonist application in comparison to control cardiomyocytes, N = 5/n
= 1 each; N, number of animals; n, number of cells. ‘*’ indicates a sig-
nificant difference in cAMP signal level from control, *P < 0.05 as
determined by one-way ANOVA followed by Bonferroni post hoc
correction.
Figure 7 SERCA2a or JPH2 overexpression in post-MI cells do not
restore the confinement of the b2AR-dependent cAMP response but
the loss of confinement can be mimicked by PTX treatment of con-
trol cells. (A) images of cardiomyocytes indicating areas of interest
(coloured ovals) situated at various distances from the point of stimula-
tion (white arrows) where FRET was measured after local selective
stimulation of b2ARs; Scale bar, 20 mm; (B) colour-coded curves of
FRET response corresponding to the four areas of interest as indicated
on the right panels; from top to bottom: Local FRET in cardiomyocytes
isolated from a heart with chronic MI after SERCA2a gene therapy N/n
= 4/14; Local FRET in cardiomyocytes from a heart with chronic MI
overexpressing JPH2 N/n = 2/7 (n = 7, from two animals); Local FRET
in normal cardiomyocytes treated with PTX N/n = 3/9. (C) Differences
of the relative b2AR-cAMP levels at progressive distances from the
point of original agonist application, average of N = 5/n = 1 each.
N, number of animals; n, number of cells.
778 S. Schobesberger et al.
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..
..arterial ligation in mice using stimulated emission depletion microscopy
reported progressive reorganization and partial elongation of T-tubules
after 4 and 8 weeks which is undetectable by conventional confocal mi-
croscopy.26 In this study, we discovered that the Z-grooves reduced
steadily over the 16 weeks in the observation period following MI, with
the appearance of smooth areas on the surface and the disappearance of
T-tubule openings (Figure 2). In contrast, severe disorganization in the re-
gularity and a moderate decrease in the density of the internal TAT net-
work were already evident at 4-week post-MI (Figure 2), and persisted
until 16-week post-MI. At 4- and 8-week post-MI, an increased amount
of longitudinal TAT elements appeared which may reflect myocardial
hypertrophy. This early increase in the amount of longitudinal tubules is
lost again at 16-week post-MI at the end-stage of HF. Similar changes
were previously reported in HF models in different species,26,35–37 which
were associated among other things to changes in Cav-3 levels.26
In our study, we observed Cav-3 dissociation early in the remodelling
phase post-MI and a late increase of the Cav-3 protein levels through to
16-week post-MI. This predominantly reflected increased Cav-3 protein
levels in the cardiomyocyte cytosol. As was shown previously in26 Cav-3
levels do not undergo a linear degradation or increase but rather
undergo differential changes in HF progression, which are also depend-
ent on the species, model and severity of HF. Wagner et al.26 reported
an increase of Cav-3 at the earlier stages, which they correlated with
increased longitudinal elements in the mouse TAT system. In our own
rat model of HF we saw no significant alterations in total Cav-3 protein
levels at 4- and 8-week post-MI, where we detected elevated numbers
of longitudinal elements. However, we detected an increase in Cav-3 at
16-week post-MI, at a time of reduced numbers of longitudinal elements
and a severely disrupted TAT system, which contained only T-tubules
that were oblique and no longer orderly aligned (see Figure 3A). Hence,
we assume Cav-3 dissociation to be partially responsible for the reorien-
tation of T-tubules into the longitudinal direction. A recent publication
studied HF in rabbit after 7.1 months of aortic insufficiency and con-
striction.38 In this rabbit model a Cav-3 protein reduction was shown to-
gether with an increased b2AR signal in the myofilament compartment
of cardiomyocytes and unaltered signalling levels at the sarcoplasmic
reticulum (SR) and plasma membrane. In our rat model at 16-week post-
MI we observe an overall decrease of b2AR signalling, potentially reflect-
ing a more advanced HF phenotype.
HF has been shown to be accompanied by cardiomyocyte dedifferen-
tiation and a reactivation of the fetal gene programme.39 Therefore, the
structural remodelling observed may also reflect a return to a more ‘fetal
phenotype’. Although investigating possible molecular mechanisms
underpinning the early structural remodelling, we found that one of the
proteins involved in the maintenance of T-tubules, JPH2, decreased dra-
matically as early as 4 weeks and remained low throughout the progres-
sion towards HF (Figure 2). JPH2 maintains the junctions between TAT
elements and the SR40 and its expression are decreased during hypertro-
phy and HF.41 Remodelling of the TAT network hence may in part be
triggered by down-regulation of JPH2. It is well established, that primary
cells in culture suffer from dedifferentiation.42 Especially the FRET ex-
periments described here have to be interpreted with this fact in mind.
During the structural investigation of cardiomyocytes after only 1 h of
culture in comparison to cardiomyocytes after 48 h of culture we
Figure 8 Schematic depiction of changes in structure and location of b2ARs during progression of heart failure. In normal cardiomyocytes the external
surface structure (Z-grooves and crests) and internal TAT network, consisting of T-tubules and longitudinal elements, is intact and b2AR are located exclu-
sively inside T-tubules; JPH2 connects T-tubules with the SR; cAMP does not diffuse far from the site of b2AR activation; and Cav 3 is predominantly in the
membrane of cells. In heart failure the surface structure regularity deteriorates progressively; First, after only 4 weeks of MI, JPH2 is downregulated; Second,
as early as 4 weeks, the amount of longitudinal elements increases, perhaps as a compensatory mechanism; At the same time b2AR-cAMP responses start to
appear at the crest, and the cAMP response is no longer confined to the site of b2AR activation; Later, at 16 weeks the deterioration of surface and T-tubule
structure continues, overall Cav 3 levels increase while the amount of longitudinal element decreases, and the overall cAMP production decreases as well,
which may be due to inefficient b2AR associated AC signalling.
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revealed TAT network damage similar to that observed in cells freshly
isolated from animals with MI 4-week post-MI (see supplementary ma-
terial online, Figure S6).
4.2 b2AR-cAMP response appearance at
crest accompanies structural remodelling
The integrity of T-tubules is intimately linked to efficient excitation–con-
traction coupling. Localized cAMP signalling, in particular via b2ARs, is
also believed to be dependent on an intact TAT network. It is important
to note that b2ARs can switch from stimulating AC-dependent cAMP
production via stimulatory Gs proteins to inhibiting it via inhibitory Gi
proteins. The latter prevents excessive bAR-mediated Gs activation and
cardiotoxicity by suppressing cAMP production through the deactivation
of G-proteins and the internalization of receptors.43 If b2ARs predomin-
antly exhibit Gi coupling, a change in cAMP levels may no longer be de-
tectable but b2ARs can still play a role in cell physiology/pathophysiology
by regulating kinase-dependent signalling and gene expression path-
ways.44 We have previously shown that in healthy cardiomyocytes, func-
tional b2ARs are exclusively situated inside T-tubules.
13 In end-stage HF,
however, functionally detectable b2AR redistribute onto surface
crests.13 In this study, we observed that after whole-cell stimulation of
b2ARs, cAMP levels were slightly decreased at 4- and 16-weeks post-MI
(Figure 4). However, they were increased at 8 weeks. The total AC activ-
ity stimulated by NKH477 was not significantly affected at the earlier
stages of remodelling (4 and 8 weeks) but was significantly reduced at
16-week post-MI. This may signify that changes in global cAMP levels
only happen in the end stage of HF. Localized stimulation via SICM nano-
pipette demonstrated a significant reduction of the b2AR-cAMP re-
sponse at 4 weeks in the T-tubules with no simultaneous increase of the
cAMP signal at the crests (Figure 5). At 8-week post-MI, local cAMP levels
increased in comparison to 4-week post-MI after stimulating at the cell
crests, explaining the changes observed in the whole-cell cAMP studies
(Figures 4 and 5). This may be attributed to a hypertrophic, compensa-
tory response of the myocardium, as well as to the appearance of the
b2AR receptor response to the crest at 8-week post-MI. An increase in
Gi protein expression but not activity has been reported in a rat HF
model,45 which makes us assume that the observed decrease of cAMP
production at 16-week post-MI is due to a reduction in AC activity and
not due to increased b2AR signalling via Gi. This is consistent with the
previous observation that b2AR expression remains unchanged during
HF.4 Our study may explain how spatial and functional b2AR alterations
can still lead to an advanced HF phenotype. Our study also shows unre-
stricted cAMP diffusion throughout the cytosol as early as 4-week post-
MI (Figure 6). The observed changes in cAMP compartmentation could
conceivably be a consequence of the extensive loss of the T-tubules and,
as we have shown previously, decreased b2AR association to the
scaffolding protein Cav-3.23 Our observations indicate that progressive
alterations in signalling initially result from reduced b2AR-cAMP produc-
tion. Consecutively, a combination of functional b2AR response appear-
ance at crests and loss of cAMP compartmentation takes place.
Alterations of the TAT system and the down regulation of JPH2 precede
the appearance of the functional b2AR response and potentially affect
the confinement of b2AR-cAMP. Interestingly, in a model with structural
recovery of the TAT network after HF using SERCA2a gene therapy,
there was no restoration of JPH2 expression, which was accompanied
by persistent diffuse b2AR-cAMP signals, even though these signals were
again exclusively inducible inside T-tubules. So, perhaps these early
changes in cell structure allow spatial rearrangement of secondary
messenger pathways and signalling via Gi proteins. Hence b2AR-cAMP
appearance at the crests may compensate for the pronounced loss in
b1AR activity reported by other groups
45,46 but ultimately contributes
to generation of HF.
4.3 Mechanisms of TAT network and b2AR
signalling rearrangement
During HF progression, we observed cellular changes which are not yet
fully understood mechanistically. In the acute period following infarction
cardiomyocytes are exposed to increased wall stress and neuro-
hormonal activation. This activates hypertrophic signalling and the devel-
opment of a hypertrophic phenotype. T-tubular structures are able to
respond to load via a stretch sensitive complex.47 The MI-induced mech-
anical overload could trigger a decrease in T-tubule regularity and dens-
ity,48 whereas longitudinal elements have been shown to temporally
increase together with Cav-3 protein aggregation.36 JPH2, which couples
the T-tubules to the SR may also be involved in stretch sensing as its
knockout leads to cell hypertrophy.48 The protein also co-localizes with
ryanodine receptors to strongly increase the efficiency of excitation–
contraction coupling,49 which is far less efficient in HF.
We have previously demonstrated that the localization of b2ARs in
non-failing ventricular myocytes depends on cholesterol-13 and Cav-
3-rich microdomains.23 Here we show that the b2AR-cAMP responses
are relocated beyond the T-tubule membranes around 8-week post-MI,
while b2ARs-dependent cAMP signalling loses its compartmentation ear-
lier at 4-week post-MI. The latter correlates temporarily with a reduc-
tion in JPH2 protein levels, dissociation of Cav-3 into the cytosol and a
parallel rise in longitudinal elements, as was reported previously in26 and
confirmed in our study at 4-week post-MI (Figure 3A,B). We have shown
previously that Cav-3 is also involved in b2AR signal regulation. Failing rat
ventricular myocytes overexpressing Cav-3 for 48 h demonstrated redis-
tribution of b2AR’s functional effects back into the T-tubules, suggesting
that Cav-3 might potentially restore the b2AR-mediated cAMP local-
ization and its confined signalling.23 In this previous publication23 we did
not measure Cav-3 protein levels at 16-week post-MI, but observed that
Cav-3 overexpression partially restored the b2-AR signal back into T-tu-
bules, which we correlated to the increased reformation of caveolae
structures. By measuring Cav-3 membrane and cytosol fractions at
4- and 16-week post-MI (Figure 3E,F,I), we now understand that Cav-3
starts dissociating into the cytosol in the early phase of remodelling post-
MI. Cav-3 remains increased in the cytosol at 16-week post-MI, and
reduced sarcolemmal Cav-3 levels may explain why b2AR-dependent
cAMP signalling levels are significantly decreased at this stage. The
observed changes in Cav-3 protein levels may contribute to the progres-
sion of HF, because Cav-3, via its scaffolding domain, binds a variety of
important signalling molecules, including PKA, via a scaffolding domain to
form signalling complexes and regulates their activity.50 Activation of PKA
by cAMP leads to a local increase in phosphodiesterase 4 activity, which
provides a negative-feedback control of the cAMP levels.13 Inhibition of
phosphodiesterase 4 by rolipram reproduced increased cAMP diffusion
in non-failing rat ventricular myocytes.13 Therefore, cAMP propagation
observed at 4-week post-MI, could be indicative of a loss of efficient
cAMP degradation via phosphodiesterases due to Cav-3-dependent dis-
ruption of PKA activity and/or localization. In addition, Cav-3 dissoci-
ation observed after MI,51 may also cause a decrease in JPH230 affecting
the bridging between the SR and TAT network as well as dissociation of
b2AR with their molecular partners within the signalosome. However,
the mechanisms underlying functional b2AR response redistribution
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from T-tubules onto crest structures still remain elusive and require fur-
ther investigation.
4.4 Conclusions and outlook
Our study reveals time-dependent alterations in the cardiomyocyte
TAT structure and the expression of structural proteins such as JPH-2
and Cav-3, which gradually alter the b2AR-cAMP response location as
well as b2AR-cAMP signalling characteristics. Our observations contrib-
ute to understanding of the biphasic remodelling of b-adrenergic signal-
ling following MI during the sub-acute and chronic phases in the
progression to HF. The identification of early JPH down-regulation, TAT
remodelling and later redistribution of functional b2AR signalling, has po-
tential implications for the optimal selection of treatment strategies to
prevent the transition from hypertrophy towards HF. We propose that
interventions to prevent the structural remodelling of the TAT system
early in the disease may maintain the TAT-SR spatial relationship, and
potentially sarcolemmal structural remodelling. For example, beta-
blockers with different b1AR:b2AR selectivity may have different actions
at progressive stages of HF development.52 This could conceivably main-
tain b2AR localization and the native spatial restriction of b2AR signalling,
and may represent a new potential therapeutic avenue.
Supplementary material
Supplementary material is available at Cardiovascular Research online.
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